内科学（第二）講座

Keyphrases

1. Left Ventricular Assist Device 51%
2. Transcatheter Aortic Valve Replacement 41%
3. Patients with Heart Failure 35%
4. Heart Failure 33%
5. Acute Decompensated Heart Failure 30%
6. Left Ventricular Assist Device Implantation 30%
7. Tolvaptan 28%
8. Transcatheter Aortic Valve Implantation 26%
9. Japan 25%
10. Clinical Outcomes 21%
11. Atrial Fibrillation 21%
12. Heart Failure Patients 20%
13. Heart Transplantation 19%
14. Heart Rate 17%
15. Confidence Interval 16%
16. Ventricular Assist Device 15%
17. Left Ventricular Assist Device Support 13%
18. Impella 12%
19. Prognostic Impact 12%
20. Left Ventricular Ejection Fraction 12%
21. Remote Dielectric Sensing 12%
22. Japanese Patients 11%
23. Hazard Ratio 11%
24. Congestive Heart Failure 11%
25. Continuous-flow Left Ventricular Assist Device (CF-LVAD) 11%
26. B-type Natriuretic Peptide 11%
27. Adaptive Servo-ventilation 11%
28. Device Implantation 10%
29. Severe Aortic Stenosis 10%
30. Heart Failure with Preserved Ejection Fraction (HFpEF) 10%
31. Beta-blockers 10%
32. Patients with Chronic Heart Failure 10%
33. All-cause Mortality 10%
34. Catheter Ablation 10%
35. Pulmonary Capillary Wedge Pressure 9%
36. Therapeutic Strategies 9%
37. Cardiovascular Mortality 9%
38. Heart Failure Hospitalization 8%
39. Cardiac Resynchronization Therapy 8%
40. Pulmonary Arterial Hypertension 8%
41. Aortic Insufficiency 8%
42. Chronic Kidney Disease 8%
43. Cardiogenic Shock 8%
44. Systolic Heart Failure 7%
45. Left Ventricular Remodeling 7%
46. Stage D Heart Failure 7%
47. Left Ventricular Function 7%
48. Valvular Interventions 7%
49. Muscle Sympathetic Nerve Activity 7%
50. Sympathetic Nerve Activity 7%
51. Adverse Events 6%
52. Ventricular Myocytes 6%
53. Combination Therapy 6%
54. Non-valvular Atrial Fibrillation 6%
55. Older Men 6%
56. Right Ventricular Function 6%
57. Odds Ratio 6%
58. Quality of Life 6%
59. Left Ventricular Dysfunction 6%
60. Paroxysmal Atrial Fibrillation 6%
61. Catheter 6%
62. Cardiac Function 6%
63. Left Ventricular Assist Device Therapy 5%
64. Pulmonary Vascular Resistance 5%
65. Lung Fluid 5%
66. Myocytes 5%
67. Mitral Regurgitation 5%
68. Ivabradine 5%
69. Chronic Heart Failure 5%
70. Hyponatremia 5%
71. Consecutive Patients 5%
72. Waon Therapy 5%
73. Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i) 5%
74. Implantable Left Ventricular Assist Device 5%
75. Right Heart Catheterization 5%
76. Heart Failure Readmission 5%
77. Poor Prognosis 5%
78. Pulmonary Congestion 5%
79. MitraClip 5%
80. Hyperkalemia 5%
81. Ventricular Fibrillation 5%
82. Ramp Test 5%
83. Cardiac Output 5%
84. Ventilation Therapy 5%
85. Arginine Vasopressin 5%
86. Everolimus 5%
87. Multicenter Registry 5%
88. Ablation 5%
89. Transesophageal Echocardiography 5%
90. Sodium Zirconium Cyclosilicate 5%
91. Risk Stratification 5%
92. Bosentan 5%
93. Ventricular Arrhythmia 5%

Medicine and Dentistry

1. Congestive Heart Failure 100%
2. Left Ventricular Assist Device 81%
3. Percutaneous Aortic Valve Replacement 71%
4. Hemodynamic 29%
5. Atrial Fibrillation 24%
6. Heart Transplantation 21%
7. Ventricular Assist Device 21%
8. Brain Natriuretic Peptide 16%
9. Hazard Ratio 15%
10. Aortic Stenosis 15%
11. Heart Left Ventricle Ejection Fraction 14%
12. Mitral Insufficiency 12%
13. Tolvaptan 12%
14. Combination Therapy 11%
15. Ablation 11%
16. Cardiovascular System 11%
17. Adverse Event 10%
18. Aortic Insufficiency 10%
19. Cardiac Resynchronization Therapy 9%
20. Assisted Circulation 9%
21. Nerve Conduction 9%
22. Cardiogenic Shock 8%
23. Ejection Fraction 8%
24. Sympathetic Nerve 8%
25. Apoplexy 8%
26. Pulmonary Artery Occlusion Pressure 8%
27. Heart Function 8%
28. Pulmonary Hypertension 8%
29. Odds Ratio 8%
30. Valvular Intervention 8%
31. Chronic Kidney Disease 7%
32. All Cause Mortality 7%
33. Recurrent Disease 7%
34. Pulmonary Artery 6%
35. Quality of Life 6%
36. Dilated Cardiomyopathy 6%
37. Systolic Heart Failure 6%
38. Device Therapy 6%
39. Paroxysmal Atrial Fibrillation 6%
40. Cardiac Catheterization 6%
41. Lung Congestion 6%
42. Scoring System 6%
43. Beta Adrenergic Receptor Blocking Agent 6%
44. Heart Graft 5%
45. Lung Fluid 5%
46. Left Ventricle 5%
47. Heart Output 5%
48. Thromboembolism 5%
49. Ivabradine 5%
50. Heart Failure with Preserved Ejection Fraction 5%
51. Kidney Function 5%
52. Ventricular Tachycardia 5%
53. Acute Decompensated Heart Failure 5%
54. Aortic Valve 5%
55. Elderly Patient 5%
56. Bleeding 5%
57. Drug Therapy 5%
58. New York Heart Association Class 5%
59. Ventricular Fibrillation 5%
60. Cannula 5%